Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease

References

• Lynch JP 3rd, Hunninghake GW. Pulmonary complications of col-lagen vascular disease. Annu Rev Med 1992;43:17–35.
   Google Scholar
• Maeda K, Kimura R, Komura K, Igarashi T. Cyclosporine treat-ment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Ftheumatol 1997;26:24–9.
   PubMed Web of Science ®Google Scholar
• Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, et al. Successful combined therapy of cyclophosp-hamide and cyclosporine for acute exacerbated interstitial pneu-monia associated with dermatomyositis. Intern Med 2000;39: 428–30.
   PubMed Web of Science ®Google Scholar
• Oddis CV, Sciurba FC, Elmagd KA, Starzl TE. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999;353:1762–3.
   PubMed Web of Science ®Google Scholar
• Schnabel A, Reuter M, Gross WL. Intravenous pulse cyclophos-phamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998;41:1215–20.
   Google Scholar
• Lin YC, Yang YH, Lin YT, Chiang BL. Steroid refractory intersti-tial pneumonitis in a patient with juvenile dermatomyositis. J Microbiol Immunol Infect 2002;35:259–61.
   PubMedGoogle Scholar
• Georganas C, Ioakimidis D, Iatrou C, Vidalaki B, Iliadou K, Athanassiou P, et al. Relapsing Wegener's granulomatosis: suc-cessful treatment with cyclosporin-A. Clin Ftheumatol 1996;15: 189–92.
   PubMed Web of Science ®Google Scholar
• Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K, et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Ftheumatology (Oxford) 2004;43:479–85.
   PubMed Web of Science ®Google Scholar
• Hamada K, Nagai S, Kitaichi M, Jin G, Shigematsu M, Nagao T, et al. Cyclophosphamide-induced late-onset lung disease. Intern Med 2003;42:82–7.
   PubMed Web of Science ®Google Scholar
• Sanchez V, Delgado JF, Morales JM, Tello R, Gomez MA, Escribano P, et al. Chronic cyclosporine-induced nephrotoxicity in heart transplant patients: Long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine. Transplant Proc 2004;36:2823–5.
   PubMed Web of Science ®Google Scholar
• Okano A, Matsusue R, Takakuwa H, Nishio A. Hepatocellular carcinoma associated with long-term cyclophosphamide therapy for Wegener granulomatosis. Intern Med 2003;42:406–9.
   PubMedGoogle Scholar
• Ohnishi H, Suzuki K, Niho T, Ito C, Yamaguchi K. Protective effects of urinary trypsin inhibitor in experimental shock. Jpn J Pharmacol 1985;39:137–44.
   Google Scholar
• Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci 1984;29:26–32.
   Google Scholar
• Endo S, Inada K, Taki K, Hoshi S, Yoshida M. Inhibitory effects of ulinastatin on the production of cytokines: implications for the prevention of septicemic shock. Clin Ther 1990;12:323–6.
   Google Scholar
• Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001;15:101–5.
   PubMed Web of Science ®Google Scholar
• Cai M, Ogawa R. Effects of free radical scavengers, methylpred-nisolone, and ulinastatin on acute xanthine and xanthine oxidase-induced lung injury in rats. Circ Shock 1994;43:71–8.
   PubMedGoogle Scholar
• Kawamura T, Inada K, Akasaka N, Wakusawa R. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth 1996;43:456–60.
   PubMedGoogle Scholar
• Aosasa S, Ono S, Seki S, Takayama E, Tadakuma T, Hiraide H, et al. Inhibitory effect of protease inhibitor on endothelial cell activation. J Surg Res 1998;80:182–7.
   PubMedGoogle Scholar
• Imada K, Ito A, Kanayama N, Terao T, Mori Y. Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/proMMP-1 and prostromelysin 1/proMMP-3 in human uterine cer-vical fibroblasts and chorionic cells. FEBS Lett 1997;417: 337–40.
   Google Scholar
• Balduyck M, Mizon C, Loutfi H, Ftichet C, Roussel P, Mizon J. The major human urinary trypsin inhibitor is a proteoglycan. Eur J Biochem 1986;158:417–22.
   PubMedGoogle Scholar
• Kuwajima S, Matsui T, Kitahashi S, Kishida T, Noda T, Izumi Y, et al. Automated measurement of trypsin inhibitor in urine with a centrifugal analyzer: comparison with other acute phase reactants. Clin Biochem 1990;23:167–71.
   PubMed Web of Science ®Google Scholar
• Pantelidis P, McGrath DS, Southcott AM, Black CM, du Bois RM. Tumor necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific. Respir Res 2001;2:365–72.
   Google Scholar
• Strausz J, Muller-Quernheim J, Steppling H, Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pul-monary fibrosis. Am Rev Respir Dis 1990;141:124–8.
   PubMed Web of Science ®Google Scholar
• Paredi P, Kharitonov SA, Loukides S, Pantelidis P, du Bois RM, Barnes PJ. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999;115:1352–6.
   PubMed Web of Science ®Google Scholar
• Nakao A, Hasegawa Y, Tsuchiya Y, Shimokata K. Expression of cell adhesion molecules in the lungs of patients with idiopathic pulmonary fibrosis. Chest 1995;108:233–9.
   PubMed Web of Science ®Google Scholar
• Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung re-modeling. Am J Respir Cell Mol Biol 2003;28:12–24.
   PubMed Web of Science ®Google Scholar
• Vassallo R, Matteson E, Thomas CF Jr. Clinical response of rheu-matoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest 2002;122:1093–6.
   Google Scholar
• Taki K, Hirahara K, Tomita S, Totoki T. Case report: Cases of recovery from paraquat poisoning without pulmonary fibrosis. Ther Res 1995;16:1219–27.
   Google Scholar
• Kamei T, Fujita J, Momoi A, Ino M, Tokuda M, Okada H, et al. Effect of ulinastatin on elastase burden and respiratory function in patients with idiopathic interstitial pneumonia (in Japanese). Kokyu 1994;13:809–14.
   Google Scholar
• Jonsson-Berling BM, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest 1991;51:549–57.
   Google Scholar
• Kato K, Nagao Y, Kurosawa M. Effect of human urinary trypsin inhibitor (ulinastatin) on inflammatory mediators from leukocytes: Possible role in the prevention of SIRS (in Japanese). Igaku To Yakugaku 1995;34:499–506.
   Google Scholar
• Sugiura Y, Nakajima K, Kawase H, Tsubota K, Fujibayashi T, Goto Y. Evaluation of a large dose intravenous administration of ulinastatin (in Japanese). Kyukyu Igaku 1988;12:1153–6.
   Google Scholar